Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Urolithiasis
Published in: Urolithiasis 2/2007

01-04-2007 | Original Paper

African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III

Authors: Nicole Stankus, Mary Hammes, Daniel Gillen, Elaine Worcester

Published in: Urolithiasis | Issue 2/2007

Login to get access

Abstract

If nephrolithiasis (NL) promotes progression to end stage renal disease (ESRD), requiring renal replacement therapy, one might expect a higher prevalence of pre-ESRD stones among ESRD versus non-ESRD subjects. We compared the prevalence of pre-ESRD stones in an African-American (AA) hemodialysis (HD) population to the estimated stone prevalence in a nationally representative cohort of AA persons as obtained by the Third National Health and Nutrition Survey (NHANES III). Face-to-face questionnaires were administered to a sample of 300 AA HD patients undergoing dialysis therapy at the University of Chicago to determine pre-ESRD NL prevalence. All data on pre-ESRD stone prevalence was confirmed by documented medical history, radiology and laboratory findings, where available. Prevalence of pre-ESRD NL in AA HD patients was 8.3% versus 2.8% in the age, race and sex adjusted NHANES III population (P < 0.001). After adjustment for age and sex, it was estimated that the prevalence of pre-ESRD kidney stones among AA HD patients is significantly higher than the prevalence of kidney stones found in the general AA population.
Literature
1.
Oren A, Husdan H, Cheng PT, Khanna R, Pierratos A, Digenis G, Oreopoulos DG (1984) Calcium oxalate kidney stones in patients on continuous ambulatory peritoneal dialysis. Kidney Int 25:534–538PubMed
2.
Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823PubMedCrossRef
3.
USRDS (2003): the United States Renal Data System. Am J Kidney Dis 42:1–230
4.
Hsu CY, Lin F, Vittinghoff E, Shlipak MG (2003) Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol 14:2902–2907PubMedCrossRef
5.
Lewandowski S, Rodgers A, Schloss I (2001) The influence of a high-oxalate/low-calcium diet on calcium oxalate renal stone risk factors in non-stone-forming black and white South African subjects. BJU Int 87:307–311PubMedCrossRef
6.
Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M (2005) Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int 67:576–591PubMedCrossRef
7.
Worcester EM, Parks JH, Evan AP, Coe FL (2006) Renal function in patients with nephrolithiasis. J Urol 176:600–603; discussion 603
8.
Evan AP, Lingeman JE, Coe FL, Parks JH, Bledsoe SB, Shao Y, Sommer AJ, Paterson RF, Kuo RL, Grynpas M (2003) Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607–616PubMedCrossRef
9.
National Center for Health Statistics (1996): Third National Health and Nutrition Examination Survey, Documentation (catalog number 76200), Hyattsville, MD, US Department of Health and Human Services (DHHS)
10.
National Center for Health Statistics (U.S.) (1996) The Third National Health and Nutrition Examination Survey (NHANES III, 1988–94) reference manuals and reports. U.S. Dept. of Health and Human Services Centers for Disease Control and Prevention National Center for Health Statistics; Supt. of Docs. U.S. G.P.O. distributor, Hyattsville, MD, Washington DC
11.
Jungers P, Joly D, Barbey F, Choukroun G, Daudon M (2004) ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis 44:799–805PubMedCrossRef
12.
Vupputuri S, Soucie JM, McClellan W, Sandler DP (2004) History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 14:222–228PubMedCrossRef
13.
Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL (2003) Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int 64:2204–2213PubMedCrossRef
14.
Gillen DL WE, Coe FL (2005) Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int 67:685–690PubMedCrossRef
Metadata
Title
African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III
Authors
Nicole Stankus
Mary Hammes
Daniel Gillen
Elaine Worcester
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 2/2007
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-007-0079-3

Other articles of this Issue 2/2007

Urolithiasis 2/2007 Go to the issue

Original Paper

Adult urolithiasis in a population-based study in Iran: prevalence, incidence, and associated risk factors

Original Paper

Percutaneous nephrolithotomy in patients with normal versus impaired renal function

Original Paper

Successful formation of calcium oxalate crystal deposition in mouse kidney by intraabdominal glyoxylate injection

Original Paper

Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function

Original Paper

Models for protein binding to calcium oxalate surfaces

Original Paper

Ureteral access sheath insertion forces: implications for design and training